TIGIT: a novel immunotherapy target moving from bench to bedside Benjamin L. SolomonIgnacio Garrido-Laguna Review 19 September 2018 Pages: 1659 - 1667
PD-1/PD-L1 co-inhibition shapes anticancer T cell immunodominance: facing the consequences of an immunological ménage à trois S. M. Mansour HaeryfarTodd D. Schell Commentary 21 August 2018 Pages: 1669 - 1672
Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients Ryo KatoMakoto YamasakiHisashi Wada Original Article 20 August 2018 Pages: 1673 - 1683
Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors Shan XieJia HuangLing Ni Original Article 20 August 2018 Pages: 1685 - 1694
IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells Julian PlaumannMelanie EngelhardtMichael Hundemer Original Article 20 August 2018 Pages: 1695 - 1707
Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicity Frank NeumannFabian AckerJoerg Thomas Bittenbring Original Article 21 August 2018 Pages: 1709 - 1718
TCR repertoire profiling of tumors, adjacent normal tissues, and peripheral blood predicts survival in nasopharyngeal carcinoma Ya-bin JinWei LuoYue-jian Wang Original Article 28 August 2018 Pages: 1719 - 1730
Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lung Matthew P. AlexanderSteven N. FieringDavid W. Mullins Original Article 23 August 2018 Pages: 1731 - 1742
Circulating CD8+ T-cell repertoires reveal the biological characteristics of tumors and clinical responses to chemotherapy in breast cancer patients Kai-Rong LinDan-Mei PangWei Luo Original Article 22 August 2018 Pages: 1743 - 1752
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer John WahbaMarina NatoliSadaf Ghaem-Maghami Original Article Open access 24 August 2018 Pages: 1753 - 1765
T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient Andreas WielandAlice O. KamphorstRafi Ahmed Original Article 22 August 2018 Pages: 1767 - 1776
Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial Yu YaoFeifei LuoLiangfu Zhou Clinical Trial Report 22 August 2018 Pages: 1777 - 1788
Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands Tonke K. RaaijmakersMarleen Ansems Focussed Research Review Open access 11 July 2018 Pages: 1789 - 1796
Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities Alexander N. R. WeberYamel Cardona GloriaOlaf-Oliver Wolz Focussed Research Review 11 September 2018 Pages: 1797 - 1807
International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain Pedro BerraondoMaria Angela AznarIgnacio Melero Meeting Report 04 September 2018 Pages: 1809 - 1813